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Key points: 17 
 We have recently shown that a high-fat high-calorie (HFHC) diet decreases whole 18 
body glucose clearance without impairing skeletal muscle insulin signalling, in 19 
healthy lean individuals.  20 
 These diets are also known to increase skeletal muscle IMTG stores, but the effect on 21 
lipid metabolites leading to skeletal muscle insulin resistance has not been 22 
investigated.  23 
 This study measured the effect of 7 days HFHC diet on: 1) skeletal muscle 24 
concentration of lipid metabolites, and 2) potential changes in the perilipin (PLIN) 25 
content of the lipid droplets (LD) storing IMTG. 26 
 The HFHC diet increased PLIN3 protein expression and redistributed PLIN2 into to 27 
LD stores in type I fibres.  28 
 The HFHC diet increased IMTG content in type I fibres, while lipid metabolite 29 
concentrations remained the same. The data suggest that the increases in IMTG stores 30 
assists reducing the accumulation of lipid metabolites known to contribute to skeletal 31 
muscle insulin resistance. 32 
  33 
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Abstract  34 
A HFHC diet reduces whole body glucose clearance without impairing skeletal muscle 35 
insulin signalling in healthy lean individuals. HFHC diets also increase skeletal muscle lipid 36 
stores. However, unlike certain lipid metabolites, intramuscular triglyceride (IMTG) stored 37 
within lipid droplets (LD) does not directly contribute to skeletal muscle insulin resistance. 38 
Increased expression of perilipin (PLIN) proteins and colocalisation to LD has been shown to 39 
assist in IMTG storage. We aimed to test the hypothesis that 7 days on a HFHC diet increases 40 
IMTG content while minimising accumulation of lipid metabolites known to disrupt skeletal 41 
muscle insulin signalling in sedentary and obese individuals.  We also aimed to identify 42 
changes in expression and subcellular distribution of proteins involved in IMTG storage. 43 
Muscle biopsies were obtained from the m. vastus lateralis of 13 (n = 11 males, n = 2 44 
females) healthy lean individuals (age: 23±2.5 y, BMI: 24.5±2.4 kg.m
-2
), following an 45 
overnight fast, before and after consuming a high-fat (64% energy) high-calorie (+47% kcal) 46 
diet for 7 days. After the HFHC diet, IMTG content increased in type I fibres only (+101%; 47 
P<0.001), whereas there was no change in the concentration of either total diacylglycerol 48 
(P=0.123) or total ceramides (P=0.150). Of the PLINs investigated, only PLIN3 content 49 
increased (+50%; P<0.01) solely in type I fibres. LDs labelled with PLIN2 increased (80%; 50 
P<0.01), also in type I fibres only. We propose that these adaptations to LD support IMTG 51 
storage and minimise accumulation of lipid metabolites to protect skeletal muscle insulin 52 
signalling following 7 days HFHC diet. 53 




Peripheral insulin resistance is a prominent feature of the type 2 diabetic phenotype 56 
(DeFronzo & Tripathy, 2009). Skeletal muscle serves as one of the largest depots for insulin-57 
stimulated glucose uptake (Katz et al., 1983; Ferrannini et al., 1985), and impairments in 58 
skeletal muscle insulin sensitivity are therefore a contributing factor to peripheral insulin 59 
resistance and ensuing hyperglycaemia. Elevated intramuscular triglyceride (IMTG) stores 60 
are associated with insulin resistance in sedentary, obese and/or type 2 diabetes individuals 61 
(Kelley et al., 1999; Goodpaster et al., 2001), but this association is not seen in endurance 62 
trained individuals as they are able to combine large IMTG stores with very high insulin 63 
sensitivity. This phenomenon is known as ‘the athlete’s paradox’ (Goodpaster et al., 2001; 64 
van Loon et al., 2004).  To understand the relationship between IMTG content and skeletal 65 
muscle insulin resistance, previous studies have used intravenous lipid/heparin infusions in 66 
order to mimic the elevated plasma fatty acid and triglyceride (TAG) supply to skeletal 67 
muscle, a characteristic of the obese and type 2 diabetic phenotype (Boden et al., 1994; Itani 68 
et al., 2002; Yu et al., 2002; Szendroedi et al., 2014). From these studies it has become 69 
apparent that IMTG per se is not mechanistically linked to impaired skeletal muscle insulin 70 
signalling. Rather, accumulation of lipid metabolites in skeletal muscle, such as 71 
diacylglycerols (DAGs) and ceramides, have been implicated in skeletal muscle insulin 72 
resistance. The relationship between DAGs and insulin resistance remains controversial 73 
however, since they are elevated in insulin-sensitive endurance-trained athletes (Amati et al., 74 
2011). Previous research has shown that these lipid metabolites directly interfere with 75 
components of the insulin signalling cascade and lead to reductions in insulin-stimulated 76 
glucose uptake (Itani et al., 2002; Yu et al., 2002; Szendroedi et al., 2014). 77 
High-fat, high-calorie (HFHC) diets provide an experimental model of lipid excess that are 78 
more physiologically relevant than that of lipid infusion protocols, as they match the dietary 79 
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habits of the 'Western world'. We, and others, have consistently shown that short-term (3-7 80 
days) adherence to a HFHC diet can reduce insulin sensitivity and glycaemic control in 81 
healthy individuals (Bakker et al., 2014; Hulston et al., 2015; Gemmink et al., 2017; Parry et 82 
al., 2017). Importantly, it was recently reported that 3 days of excessive dietary fat intake 83 
reduced insulin-stimulated leg glucose uptake without changes in skeletal muscle signalling 84 
(Lundsgaard et al., 2017). This is very similar to our own observations, where 7 days on a 85 
HFHC diet resulted in reduced postprandial glycaemic control that was attributable to 86 
reduced glucose clearance (determined using dual-glucose tracers during an oral glucose 87 
challenge) despite maintained skeletal muscle insulin signalling (Parry et al., 2019). Based on 88 
this observation, we hypothesise that the lipid metabolites known to lead to skeletal muscle 89 
insulin resistance in sedentary, obese and type 2 diabetes individuals are not elevated when 90 
healthy lean individuals consume a 7-days HFHC diet and that most of the diet-derived fatty 91 
acids (FA) will be stored as IMTG instead.  92 
IMTG is stored within lipid droplets (LD) which are coated by a phospholipid monolayer, 93 
decorated with numerous proteins (Bersuker & Olzmann, 2017). The most extensively 94 
studied of these proteins is the perilipin (PLIN) family of proteins. Increases in the protein 95 
expression of PLIN2 and/or PLIN5 occur alongside elevations in IMTG content induced by 96 
exercise training (Shaw et al., 2012; Shepherd et al., 2013; Shepherd et al., 2014) or a HFHC 97 
diet (Gemmink et al., 2017), indicating that the PLIN proteins play a role in IMTG storage. In 98 
support, myotubes overexpressing PLIN3 accumulate IMTG (Kleinert et al., 2016), and 99 
PLIN5 overexpression in primary human myotubes or rat skeletal muscle augments IMTG 100 
content whilst restricting accumulation of lipid metabolites (DAGs or ceramides) 101 
concomitant to preserved insulin sensitivity (Bosma et al., 2013; Laurens et al., 2016). Not 102 
only is the protein expression of the PLIN proteins important, but also their distribution 103 
across LDs.  We have previously shown that LDs with PLIN attached are targeted for 104 
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breakdown during exercise (Shepherd et al., 2012, 2013). Moreover, reductions in insulin 105 
sensitivity in response to prolonged fasting are least severe in those individuals who can 106 
redistribute PLIN5 across an expanded LD pool (Gemmink et al., 2016). This suggests that 107 
increasing the number of LDs with PLIN proteins on the LD surface may help to alleviate 108 
lipid-induced insulin resistance. This mechanism may explain the observation recently made 109 
by our group (Parry et al., 2019) that skeletal muscle insulin signalling is maintained 110 
following 7 days on a HFHC diet.  111 
The primary aim of this study was to test the hypothesis that in healthy individuals that have 112 
consumed a HFHC diet for 7 days there is an increase in IMTG stores and a reduction or no 113 
change in the concentration of lipid metabolites known to disrupt the insulin signalling 114 
cascade in insulin resistant states. Fibre type and subcellular distribution of IMTG, as well as 115 
the size of LD containing IMTG are all closely linked to insulin resistance (Chee et al., 2016; 116 
Nielsen et al., 2017; Daemen et al., 2018). To detect nuanced changes in IMTG stores 117 
following a HFHC diet we employed our previously validated microscopy techniques 118 
(Shepherd et al., 2012, 2013; Shepherd et al., 2017) to allow us to investigate changes in LD 119 
morphology and subcellular distribution on a fibre type-specific basis. PLIN proteins have 120 
been implicated in IMTG storage and therefore we also hypothesised that there would be an 121 
increase in PLIN protein content and PLIN colocalisation to LD following the HFHC diet.  122 




Participants and ethical approval  125 
The samples used in this study were collected as part of a previous study investigating the 126 
effect of 7 days HFHC diet on glucose kinetics and insulin sensitivity (Parry et al., 2019). 127 
Muscle samples from 13 healthy individuals (n = 11 males and n = 2 females, (age: 23±1 y, 128 
BMI: 24.5±0.7 kg.m
-2
) were used for the analysis of this study, with the informed consent 129 
provided originally covering this subsequent use.
 
All participants were physically active 130 
(taking part in at least 3 x 30 min of moderate-intensity physical activity each week), non-131 
smokers, with no diagnosis of cardiovascular or metabolic disease, not taking any medication 132 
known to interfere with the study outcomes, and weight stable for at least 3 months. The 133 
study adhered to the Declaration of Helsinki and was approved (R13-P171) by Loughborough 134 
University Subcommittee Ethical Committee for Human Participants. All participants 135 
provided written informed consent. The study was registered at ClinicalTrials.gov (identifier: 136 
NCT03879187).  137 
Pre-testing 138 
Prior to the start of the study, participants attended the laboratory for an initial assessment of 139 
their baseline anthropometric characteristics (height, body mass and BMI). This information 140 
was then used to estimate resting energy expenditure (REE) (Mifflin et al., 1990). A standard 141 
correction for physical activity (1.6 and 1.7 times REE for females and males, respectively) 142 
was applied in order to estimate total daily energy requirements. This information was then 143 
used to determine individual energy intakes for the experimental diet intervention (Parry et 144 
al., 2017). 145 
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Experimental protocol 146 
Participants consumed a high-fat (64% energy), high-calorie (+47% kcal) (HFHC) diet for 7 147 
days. The diet provided 4646 ± 194 kcal per day, with 185 ± 9 g [16% total energy (TE)] 148 
protein, 233 ± 9 g [20% TE] carbohydrate, and 325 ± 15 g [64% TE] fat intake. Saturated fat 149 
intake was 140 ± 6 g [27.5% TE]. All foods were purchased and prepared by the research 150 
team. Participants were instructed to eat everything that was provided, not to eat any 151 
additional food, and to return any uneaten items so that diet values could be adjusted if 152 
necessary. All participants were informed about the importance of strict diet adherence. 153 
Adherence was checked by daily interviews that were conducted when participants collected 154 
their food bundles. Muscle biopsies were performed before and after the HFHC diet. Biopsies 155 
were performed after an overnight fast (>12 h), having refrained from strenuous physical 156 
activity for ≥ 48 h. Samples were obtained from the m. vastus lateralis under local 157 
anaesthesia using the Bergstrom needle biopsy technique with suction (Bergstrӧm, 1975). 158 
Following removal of excess blood, fat and connective tissue, a portion of muscle (10-30 mg) 159 
was mounted in Tissue-Tek OCT (Sakura Finetek UK Ltd) and frozen in liquid nitrogen-160 
cooled isopentane for subsequent immunohistochemical analyses. Another portion of muscle 161 
tissue (20-30 mg) was freeze-dried, dissected and cleaned for biochemical lipid metabolite 162 
analysis.  163 
Lipid composition analysis  164 
Approximately 5 mg of freeze-dried muscle tissue (20-30 mg wet weight) was used for the 165 
lipid composition analysis using the butanol:methanol [3:1] (BUME) method (Lofgren et al., 166 
2016). Briefly BUME solution was added to samples at -20
o
C and combined tissue 167 
homogenization and lipid extraction were then performed using a Mixer Mill 301 instrument 168 
(Retsch GmbH, Haan, Germany). Automated liquid handling steps in the extraction 169 
procedure were performed by a Velocity 11 Bravo pipetting robot (Agilent technologies, 170 
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Santa Clara, CA, USA). Total lipid extracts were stored in chloroform/methanol (2:1) at -171 
20
o
C until further analysis.  Prior to mass spectrometric analysis DAG was fractionated using 172 
straight-phase high-performance liquid-chromatography (HPLC) and ELS detection as 173 
previously described (17). For mass spectrometric analysis, total lipid extracts, as well as the 174 
DAG fractions, were diluted with internal standard-containing chloroform/methanol (1:2) 175 
with 5mM ammonium acetate. TAG and DAG were then quantified by direct infusion 176 
(shotgun) on a QTRAP 5500 mass spectrometer (Sciex, Concord, Canada) equipped with a 177 
robotic nanoflow ion source, TriVersa NanoMate (Advion BioSciences, Ithaca, NJ) 178 
performed in positive ion mode by neutral loss detection of 10 common acyl fragments 179 
formed during collision induced dissociation, according to previous work (Murphy et al., 180 
2007). Lipid class-specific internal standards were used of either deuterated or 181 
diheptadecanoyl (C17:0) containing fatty acids. 182 
Ceramides were analysed using UPLC-MS/MS according to previous work (Amrutkar et al., 183 
2015). Prior to ceramide analysis the total extract was exposed to alkaline hydrolysis (0.1M 184 
potassium hydroxide in methanol) to remove phospholipids that could potentially cause ion 185 
suppression effects. After hydrolysis the samples were reconstituted in 186 
chloroform:methanol:water [3:6:2]. Ceramides were then quantified using a QTRAP 5500 187 
mass spectrometer equipped with an Infinity quaternary ultra-performance pump (Agilent 188 
Technologies, Santa Clara, CA)189 
Immunohistochemistry analysis  190 
Serial cryosections (5 μm) were cut at -30
o
C onto ethanol-cleaned glass slides. Cryosections 191 
of samples obtained pre and post 7 days HFHC diet from one participant were placed on a 192 
single slide to account for any variation in staining intensity between sections. Sections were 193 
fixed for 1 h in 3.7% formaldehyde, rinsed 3 x 30 s in doubly distilled water (dd H2O) and 194 
permeabilised in 0.5% Triton X-100 for 5 min, before being washed 3 x 5 min in Phosphate 195 
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Buffered Saline (PBS, 137mM sodium chloride, 3 mM potassium chloride, 8 mM sodium 196 
phosphate dibasic and 3mM potassium phosphate monobasic, pH of 7.4). Slides were 197 
incubated for 1 h with primary antibodies, washed 3 x 5 min in PBS, incubated with 198 
complementary secondary fluorescence-conjugated antibodies for 30 min, followed by a 199 
further 3 x 5 min PBS washes. To visualise IMTG, LD were incubated for 20 min with the 200 
free fluorochrome BODIPY 493/503 (Invitrogen, Paisley, UK, D3922), which due to its 201 
lipophobic nature partitions into the core of LDs. Following a single 5 min PBS wash, 202 
coverslips were mounted with Vectashield (H-1000, Vector Laboratories, Burlingame, CA, 203 
USA) and sealed with nail varnish.  204 
Antibodies and staining combinations  205 
The primary antibodies used were guinea pig anti-adipophilin (PLIN2) and guinea pig anti-206 
OXPAT (PLIN5: both Progen, GP40 & GP31 respectively, Biotechnik, Heidelberg, 207 
Germany), rabbit anti-perilipin 3/TIP-47 (PLIN3: NB110-40764 Novus Biologicals, 208 
Cambridge, UK), mouse anti-OxPhos Complex IV subunit I (COXIV; used as a marker of 209 
muscle oxidative capacity: 459600, ThermoFisher Scientific, Paisley, UK), mouse anti-210 
dystrophin (used as a plasma membrane marker: D8168, Sigma-Aldrich, Dorset UK). Cell 211 
border visualisation was achieved with either rabbit anti-laminin (L9393, Sigma-Aldrich, 212 
Dorset, UK) or with wheat germ agglutinin (WGA) Alexa Fluor 633 conjugate 213 
(ThermoFisher Scientific, Paisley, UK). Muscle fibre type was determined using mouse anti-214 
myosin heavy chain I (MHCI) (A4.840c) and mouse anti-myosin heavy chain IIa (MHCIIa) 215 
(N2.261c; both DSHB, University of Iowa, USA developed by Dr. Blau). Appropriate Alexa 216 
Fluor secondary antibodies were obtained from ThermoFisher Scientific (Paisley, UK). 217 
To determine fibre type-specific protein expression, primary antibodies targeting PLIN2, 218 
PLIN3, PLIN5 or COXIV, or BODIPY 493/503 to stain for IMTG, were used in combination 219 
with antibodies targeting fibre type (MHCI, MHCIIa) and the cell border (either laminin or 220 
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WGA Alexa Fluor 633 conjugate). To investigate colocalisation between PLIN proteins and 221 
LD, PLIN2, PLIN3 or PLIN5 were stained in combination with BODIPY 493/503, and 222 
antibodies targeting fibre type (MHCI and MHCIIa).   223 
Image capture, processing and data analysis 224 
All images were captured using an inverted confocal microscope (Zeiss LSM710; Carl Zeiss 225 
AG, Oberkochen, Germany) with a 63x 1.4 NA oil immersion objective. A diode laser was 226 
used to excite the Alexa Fluor 405 fluorophore, an argon laser for the Alexa Fluor 488 227 
fluorophore and BODIPY 493/503 and a helium-neon laser for the Alexa Fluor 546 and 633 228 
fluorophores.   229 
To assess IMTG content, and the protein expression of the PLIN proteins and COXIV cross-230 
sectional images were obtained at 1.1x digital zoom. Type I and type IIa fibres were 231 
identified through positive staining, and any fibres without positive staining for either MHCI 232 
or MHCIIa were assumed to be type IIx fibres. For type I and IIa fibres 10 images per fibre-233 
type per participant pre and post the HFHC diet for each assay was obtained (equating to a 234 
total of 260 images per assay). This was not possible for type IIx fibres due to a low number 235 
of these fibres in muscle sections in a number of participants. Type IIx fibres were included 236 
in the analyses if it was possible to obtain 4 or more images of type IIx fibres per time point 237 
for a participant. This equated to an average of 71 ± 11 images of type IIx fibres being used 238 
in the 5 assays that we were able to acquire a sufficient quantity of type IIx fibres to be used 239 
in statistical analyses.  Image analysis was undertaken using Image-Pro Plus, version 5.1 240 
(Media Cybernetics, Bethesda, MD, USA). To assess IMTG and PLIN protein content within 241 
each muscle fibre, the fibre was first separated into a peripheral region (first 5 μm from the 242 
cell border) and the central region (remainder of the cell; Figure 1). A selected intensity 243 
threshold was used to represent a positive signal for IMTG and each PLIN protein. IMTG and 244 
PLIN protein content was expressed as the positively stained area fraction relative to the total 245 
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area of the peripheral region or central region of each muscle fibre. Data was also extracted to 246 
examine LD number (number of LDs expressed relative to area) and LD size (mean area of 247 
individual LDs). COXIV fluorescence intensity was calculated using optical density in the 248 
peripheral and central regions of the cell and normalised to each individual peripheral and 249 
central area.  250 
As previously described (Shepherd et al., 2013; Strauss et al., 2016; Whytock et al., 2018), 251 
before any colocalisation analysis was undertaken controls were included to confirm absence 252 
of 1) bleed through of fluorophores in opposing channels when single staining was 253 
performed, 2) non-specific secondary antibody binding, and 3) sample autofluorescence. For 254 
colocalisation analysis of PLIN proteins with LD, images were obtained at 4x digital zoom 255 
applied to both the centre region and the peripheral region of type I and type IIa muscle fibres 256 
pre and post the HFHC diet (n=10 images per region, per fibre-type, pre and post HFHC diet, 257 
per participant, equating to a total of 80 images for each participant for each staining 258 
protocol; Figure 2). Object-based colocalisation analysis was performed separately for 259 
PLIN2, PLIN3 and PLIN5 with LD, as previously described (Shepherd et al., 2012, 2013; 260 
Shepherd et al., 2017). Briefly, a selected intensity threshold was used to denote a positive 261 
signal for each PLIN protein of interest and LD. These thresholds were used to produce 262 
binary images of the PLIN protein and LD used for the colocalisation analysis (Figure 2B and 263 
C). Binary images were merged to produce a colocalisation map and overlapping regions 264 
extracted to a separate image (Figure 2D and E). The number of extracted objects was 265 
calculated and expressed relative to area to represent the number of PLIN-associated LD 266 
(PLIN+ LD). The number of extracted objects was subtracted from the total number of LD 267 
and expressed relative to area to represent the number of LD not associated with PLIN 268 
(PLIN- LD). Additionally, the number of extracted objects was subtracted from the total 269 
number of PLIN objects and expressed relative to area to identify the amount of free PLIN 270 
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protein not associated with LD. The fraction of PLIN protein colocalising to LD was also 271 
reported. When conducting the colocalisation analysis, if there were multiple PLIN objects 272 
localised to a single LD this was classified as one colocalisation count, in order to avoid over 273 
estimation of PLIN+ LD.  274 
Statistics 275 
All data is reported as the mean ± SD, including the figures. Significance was set at P < 0.05. 276 
A paired t-test was used to compare overall results from pre to post HFHC diet. A linear 277 
mixed-effects model with fixed effects for fibre-type (type I vs type IIa vs type IIx), region 278 
(central vs peripheral) and time (pre vs post HFHC diet) and random effects to account for 279 
repeated measurements within subjects was used. Significant main effects or interaction 280 
effects were assessed using Bonferroni adjustment post hoc analysis.  281 
Results 282 
Lipid metabolites 283 
Total TAG did not change from pre (22.53 ± 30.32 nmol/mg tissue) to post the HFHC diet 284 
(11.91 ± 15.02 nmol/mg tissue; P = 0.34; Figure 3A). From pre to post HFHC diet there was 285 
also no changes in total DAG content (1.63 ± 1.85 and 0.67 ± 0.84 nmol/mg tissue pre and 286 
post HFHC diet respectively; P = 0.123; Figure 3B) or total ceramide content (169.30 ± 287 
194.54 and 74.42 ± 7.48 pmol/mg tissue pre and post HFHC diet respectively; P = 0.150; 288 
Figure 3C). Individual species of DAG (Figure 3D) and ceramides (Figure 3E) also showed 289 
no changes from pre to post HFHC diet. 290 
IMTG analysis 291 
At baseline, type I fibres had greater IMTG content (expressed as percentage of fibre stained) 292 
in comparison to type IIa (P = 0.006) and type IIx fibres (P < 0.001), although there was no 293 
difference between type IIa and type IIx fibres (P = 0.467; Figure 4A). There was also no 294 
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significant differences in IMTG content at baseline between the peripheral and central region 295 
of the cell (P = 0.399). Following the HFHC diet there was an increase in IMTG content that 296 
was exclusive to type I fibres only (+101%; P < 0.001), and this occurred in both the 297 
peripheral (+89%; P < 0.001) and central regions (+103; P < 0.001). Although overall IMTG 298 
content did not increase in type IIa or IIx fibres, IMTG content did increase in the peripheral 299 
region of both fibres following the HFHC diet (type IIa fibres +117%; P = 0.016; and type 300 
IIx fibres +134%; P =0.016). Consequently, following the HFHC diet IMTG content was 301 
greater in the peripheral region of muscle fibres compared to the central region (P = 0.022). 302 
The increase in IMTG content in type I fibres was due to an increase in both LD size (+44%; 303 
P < 0.001; Figure 4B) and LD number (+43%; P < 0.001; Figure 4C) in both muscle fibre 304 
regions. Although overall IMTG content was not augmented by HFHC diet in type IIa and 305 
type IIx fibres, we did observe an increase in LD size in both the peripheral (+36% and +30% 306 
for type IIa and IIx respectively; P < 0.01) and central region (+47% and +46% for type IIa 307 
and IIx fibres respectively; P < 0.001) of these fibres. LD number increased in the peripheral 308 
region of type IIa fibres (+57%; P =0.014) whereas there were no differences in the 309 
peripheral region of type IIx fibres. There were no changes in LD number in the central 310 
region of type IIa fibres (P = 0.376) and type IIx fibres (P =0.140) after the HFHC diet.  311 
PLIN protein expression 312 
PLIN2 313 
At baseline, PLIN2 protein expression (expressed as percentage of fibre stained) was 314 
significantly greater in type I fibres in comparison to type IIa (P = 0.048) and type IIx fibres 315 
(P = 0.019), however, there was no difference between type IIa and type IIx fibres (P = 316 
0.112; Figure 5A). There were also no differences in PLIN2 protein expression between the 317 
central and peripheral region. Furthermore, following the HFHC diet there was no changes in 318 




PLIN3 protein expression was higher in type I fibres compared to type IIx fibres only (P = 321 
0.021; Figure 5B), whereas there were no differences between type IIa and IIx fibres. There 322 
were also no differences in PLIN3 protein expression between the peripheral and central 323 
region of the muscle fibre (Figure 5B). Following the HFHC diet there was an increase in 324 
PLIN3 protein expression in type I fibres only (+50%; P = 0.010), occurring in both the 325 
peripheral (+35%) and central region of the muscle fibre (+58%). The increase in type I 326 
fibres resulted in a significantly higher PLIN3 protein expression in type I fibres compared to 327 
type IIa (P = 0.001) and IIx (P < 0.001) after the HFHC diet. Although overall PLIN3 protein 328 
expression in type IIa fibres did not change there was an increase in PLIN3 protein 329 
expression in the peripheral region of type IIa fibres (+58%; P = 0.043). 330 
PLIN5 331 
At baseline, there was significantly more PLIN5 protein expression in type I fibres compared 332 
to type IIa (P = 0.001) and type IIx (P = 0.001), although there were no differences between 333 
type IIa and IIx fibres (P = 1.000; Figure 5C). PLIN5 protein expression was also greater in 334 
the peripheral region of the muscle fibres compared to the central region (P = 0.001). Overall 335 
PLIN5 protein expression did not increase with the HFHC diet (P = 0.342). 336 
LD and PLIN protein colocalisation 337 
Colocalisation analysis was only conducted on type I and IIa fibres due to insufficient type 338 
IIx fibres being acquired during image capture.   339 
PLIN2 340 
At baseline, the fraction of PLIN2 colocalising to LD was higher in type I fibres (0.41 ± 0.14) 341 
compared to type IIa (0.31 ± 0.13 ; P = 0.001), with no differences between the central region 342 
(0.36 ± 0.15) and the peripheral region (0.36 ± 0.15; P = 0.918). Following the HFHC diet 343 
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there was an increase in the fraction of PLIN2 colocalising to LD in type I fibres only (+26%; 344 
P =0.001), due to increases in both the peripheral (32%; P = 0.006) and central regions 345 
(+25%; P = 0.031). At baseline, type I fibres had significantly more PLIN2+ LD in 346 
comparison to type IIa fibres (P = 0.001) and there was more PLIN2+ LD in the peripheral 347 
region of muscle fibres compared to the central region (P < 0.001; Figure 6A). Following the 348 
HFHC diet there was an increase in PLIN2+ LD in type I fibres only (+80%; P = 0.005; 349 
Figure 6A), due to increases in both the peripheral (+78%; P = 0.002) and the central regions 350 
(+83%; P = 0.017; Figure 6A). There were more PLIN2- LD in type I compared to type IIa 351 
fibres (P < 0.001), but no difference in the proportion of PLIN2- LD in the peripheral and 352 
central region of muscle fibres at baseline (P = 0.446; Figure 7B), and this relationship did 353 
not change with the HFHC diet. At baseline, the peripheral region of muscle fibres had higher 354 
amounts of free PLIN2 (0.065 ± 0.027 μm
-2
) compared to central (0.041 ± 0.021 μm
-2
; P < 355 
0.001), however there were no differences between fibre types, and this was unaltered after 356 
the HFHC diet. In summary, in type I fibres there was an increase in the fraction of PLIN2 357 
colocalising to LD which resulted in an increase in PLIN2+ LD.  358 
PLIN3 359 
At baseline, the fraction of PLIN3 colocalising to LD was higher in type I fibres (0.32 ± 0.12) 360 
compared to type IIa (0.22 ± 0.13; P < 0.001), with no differences between the central region 361 
(0.26 ± 0.14) and the peripheral region (0.28 ± 0.13; P = 0.628). Following the HFHC diet 362 
there was an increase in the fraction of PLIN3 colocalising to LD in both type I fibres (+44%; 363 
P < 0.001) and type IIa fibres (+39%; P = 0.002). In type I fibres this was due to increases in 364 
both the peripheral (60%; P < 0.001) and central regions (29%; P = 0.012). In type IIa fibres 365 
however only the central region observed a significant increase (66%; P = 0.001). Type I 366 
fibres had significantly more PLIN3+ and PLIN3- LD in comparison to type IIa fibres (P < 367 
0.001), but the proportion of PLIN3+ and PLIN3- LD in the peripheral and central region of 368 
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muscle fibres was not different (P = 0.219; Figure 6C-D). The HFHC diet did not change the 369 
number of PLIN3+ LD.  However, following the HFHC diet there was a significant increase 370 
in PLIN3- LD in both type I (+58%; P < 0.001) and type IIa fibres (+43%; P = 0.017; Figure 371 
6D). In type I fibres the increase was observed in both the peripheral (+69%; P < 0.001) and 372 
central regions (+47%; P = 0.001), whereas in type IIa fibres there was only an increase in 373 
the peripheral region (+40%; P = 0.026, Figure 7D). There was no difference in free PLIN3 374 
in any fibre type or any region at baseline. The HFHC diet reduced free PLIN3 in type I 375 
fibres exclusively (0.071 ± 0.021 to 0.050 ± 0.028 μm
-2
; P = 0.010) which occurred in the 376 
peripheral region only (-36%; P = 0.002). To recap, there was an increase in the fraction of 377 
PLIN3 colocalising to LD in both type I and IIa fibres, but this did not result in an increase in 378 
PLIN3+ LD.    379 
PLIN5 380 
At baseline, the fraction of PLIN5 colocalising to LD was similar between type I fibres (0.56 381 
± 0.14) and type IIa (0.49 ± 0.16; P = 0.095), with no differences between the central region 382 
(0.54 ± 0.15) and the peripheral region (0.50 ± 0.15; P = 0.416). Following the HFHC diet 383 
there was an increase in the fraction of PLIN5 colocalising to LD in both type I fibres (+27%; 384 
P = 0.001) and type IIa fibres (+19%; P = 0.027), due to similar increases in central and 385 
peripheral region for both fibre types. There was more PLIN5+ LD in type I compared to 386 
type IIa fibres (P < 0.001) and in the peripheral region compared to the central region (P < 387 
0.001), but this relationship was unchanged with the HFHC diet (Figure 6E). The number of 388 
PLIN5- LD was not different between fibre types and regions and this was not altered 389 
following the HFHC diet (Figure 6F). Free PLIN5 was significantly higher in type I (0.048 ± 390 
0.026 µm
-2
) in comparison to type IIa fibres (0.032 ± 0.019 µm
-2
; P = 0.003) and in the 391 
peripheral region across fibre types (0.049 ± 0.026 µm
-2
) compared to the central region 392 
(0.031 ± 0.018 µm
-2
; P < 0.001) and this was unaltered with the HFHC diet. In summary, 393 
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there was an increase in the fraction of PLIN5 colocalising to LD in both type I and IIa fibres, 394 
but this did not alter the number of PLIN5+ LD.  395 
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COXIV fluorescence intensity 396 
Mitochondria 397 
COXIV protein expression, representing mitochondrial content, displayed a hierarchical fibre 398 
type distribution such that type I fibres (64 ± 29AU) was significantly higher in comparison to 399 
type IIa (55 ± 25 AU; P = 0.034), and type IIa fibres was significantly higher than type IIx fibres 400 
(52 ± 24; P = 0.030).  There was also greater COXIV protein expression in the peripheral region 401 
(70 ± 30 AU) compared to the central region across fibres (55 ± 26 AU; P < 0.001). The HFHC 402 
diet did not change COXIV protein expression in any fibre type or any region. 403 




The overlying aim of the present study was to examine the effects of consuming a HFHC diet for 406 
7 days on intramuscular lipid storage and the expression and subcellular distribution of key 407 
proteins related to lipid metabolism, in healthy lean individuals. The first major finding was that 408 
the HFHC diet increased IMTG content exclusively in type I fibres, due to an increase in both 409 
LD size and number whilst whole muscle levels of ceramides and DAGs were unaltered. PLIN3 410 
was the only PLIN protein to exhibit increased expression after 7 days HFHC diet, but this was 411 
not mirrored by an increase in PLIN3+ LD. Rather, we observed an increased number of PLIN2+ 412 
LD in type I fibres. We review these adaptations in the context of our previous findings showing  413 
a decrease in glucose clearance and reduced glycaemic control, despite maintenance of normal 414 
skeletal muscle insulin signalling in these subjects (Parry et al., 2019). Together, the data shows 415 
that a 7-day HFHC diet leads to increased IMTG storage alongside, increases in PLIN3 protein 416 
expression and PLIN2+ LD.  Moreover, the increase in IMTG may contribute to the maintenance 417 
of skeletal muscle insulin signalling by minimising the accumulation of inhibitory lipid 418 
metabolites.  419 
As previously mentioned our healthy lean subjects in this study experienced a decrease in 420 
glucose clearance and reduced glycaemic control after 7 days on the HFHC diet, without 421 
impairments in the phosphorylation of key insulin signalling intermediates (Akt and AS160) 422 
(Parry et al., 2019). Accumulation of ceramide in skeletal muscle dephosphorylates Akt via 423 
activation of protein phosphatase 2A (Stratford et al., 2004). There is some contention as to 424 
DAG’s role in the mechanisms leading to skeletal muscle insulin resistance (Amati et al., 2011; 425 
Chow et al., 2014). Despite this, certain DAG species have been shown to activate novel PKC 426 
isoforms which phosphorylate IRS-1 on serine residues and subsequently inhibit IRS-1 tyrosine 427 
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phosphorylation (Yu et al., 2002; Szendroedi et al., 2014), and therefore downstream activation 428 
of Akt and AS160. Thus, the finding that the HFHC diet did not affect either ceramide or DAG 429 
concentrations is entirely in keeping with the observation of normal phosphorylation of Akt and 430 
AS160. 431 
The absence of any alterations in fasting ceramide and DAG concentrations is indicative of 432 
dietary FA instead being directed stored as IMTG, if not directed to mitochondria for β-433 
oxidation. First, we observed no differences in whole muscle TAG levels in response to the 434 
HFHC diet, which is in contrast to a recent study showing that 5 days of a HFHC diet augmented 435 
whole muscle TAG (Gemmink et al., 2017). However, it is now well established that IMTG 436 
content can change in a fibre type-specific manner (Shepherd et al., 2012, 2013). For example, 437 
IMTG accumulation following 6 h lipid infusion during a hyperinsulinaemic-euglycaemic clamp 438 
is specific to type I fibres only (Shepherd et al., 2017).  Therefore, we investigated fibre-type 439 
specific changes in IMTG content and demonstrate for the first time that a short-term HFHC diet 440 
augments IMTG content exclusively in type I fibres. This finding is perhaps unsurprising 441 
considering that type I fibres are characterised by a higher mitochondrial content, a greater 442 
abundance of lipolytic regulatory proteins, and an enhanced ability to utilise IMTG stores during 443 
moderate-intensity exercise (Shepherd et al., 2013; Watt & Cheng, 2017). Therefore, type I 444 
fibres are appreciably more equipped to store an influx of dietary FA as IMTG. When muscle 445 
lipid content was determined from whole muscle homogenates, there was no difference in overall 446 
TAG levels from pre to post HFHC diet. It is possible however that these measurements may 447 
have been confounded by the presence of extramyocellular LDs  (Guo, 2001). Whilst the bulk of 448 
TAG in mammalian cells is stored in LD (Wolins et al., 2001; Kuramoto et al., 2012), 449 
particularly in the fasted state (Kuramoto et al., 2012), this has yet to be confirmed in skeletal 450 
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muscle.  Therefore, although we observed an increase in the amount of TAG stored in LD in type 451 
I fibres, we cannot exclude the possibility that extra-LD TAG levels were unchanged but could 452 
not be measured on a fibre-type specific basis with the current methodology. Type I fibres also 453 
only account for approximately 40% of all fibres in the v. lateralis muscle of young participants 454 
(Staron et al., 2000). It is possible, therefore, that the observed increase in IMTG in type I fibres 455 
only may not lead to an overall increase in whole-muscle TAG concentrations.  456 
We also examined changes in IMTG content on a subcellular-specific basis, as well as exploring 457 
adaptations to LD morphology. In this respect, increased IMTG content in type I fibres following 458 
the HFHC diet occurred in both the peripheral and central region of the fibres and was due to an 459 
increase in both LD size and number. Seven days on the HFHC diet also augmented IMTG 460 
content, specifically in the peripheral region of both type II fibres which was again due to 461 
elevations in both LD size and number. Interestingly, HFHC diet increased LD size in the central 462 
region of both type II fibres, although this did not result in increased IMTG content. These 463 
distinct patterns of fibre and region-specific IMTG accumulation and changes in LD morphology 464 
are the first of their kind in the literature. Moreover, they are indicative of the progression of 465 
IMTG accumulation in muscle, whereby lipid accumulates in type I fibres prior to type II fibres, 466 
changes in LD size precede an increase in LD number, and this occurs in the peripheral region of 467 
the cell before the central region. 468 
Increased IMTG content near the plasma membrane of muscle fibres has been associated with 469 
insulin resistance (Chee et al., 2016) particularly if IMTG is stored in larger LD (Nielsen et al., 470 
2017; Daemen et al., 2018). Accumulation of IMTG close to the plasma membrane may be 471 
detrimental due to the close proximity to key components of the insulin signalling cascade. In 472 
particular, increases in LD size rather than number near the plasma membrane will be less 473 
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favourable because larger LD have a lower surface area to volume ratio which is proposed to 474 
result in lower IMTG turnover and subsequent accumulation of lipid metabolites. In this study, 475 
the peripheral region was defined as an area within the muscle fibres that was distinct from the 476 
central region of the cell but in close proximity to the plasma membrane and therefore near to 477 
insulin signalling and trafficking of FA into the myocyte. The predominant increase in IMTG 478 
stores occurred in type I fibres and this was accountable to an increase in LD size and number in 479 
both the peripheral and central regions.  480 
During LD expansion the increased distance between phospholipid molecules recruits specific 481 
proteins via increased surface tensions (Krahmer et al., 2011). This recruitment has been 482 
proposed to be a mechanism of metabolic regulation (Hesselink et al., 2017). Consistent with 483 
this hypothesis, Gemmink et al. (2016) found that LD size and number increased following acute 484 
elevation of FFA from prolonged fasting.  Importantly though, those LDs that increased in size 485 
and number were also labelled with PLIN5. Furthermore, the individuals who had the largest 486 
increase in IMTG content also exhibited the smallest reduction in insulin sensitivity (Gemmink 487 
et al., 2016). Therefore, larger LDs may not necessarily impede insulin sensitivity if they are 488 
decorated with PLIN proteins. 489 
In the present study, PLIN3 protein expression increased specifically in type I fibres following 490 
the HFHC diet. PLIN3 has been linked to formation of new LD following lipid loading in 491 
cultured differentiated adipocytes (Wolins et al., 2005). If a similar role exists in skeletal muscle, 492 
we might have expected to see an increase in PLIN3+ LD following the HFHC diet; however, 493 
only an increase in PLIN3- LD was observed. There was, however, a reduction in free PLIN3 in 494 
type I fibres with an increase in the fraction of PLIN3 colocalising to LD. Taken together, these 495 
data indicate that PLIN3 is targeted to LD that already have PLIN3 associated and therefore 496 
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suggests that PLIN3 supports LD growth and stability, rather than increase in LD number in 497 
skeletal muscle.  Whether having more PLIN3 localised to the LD supports greater IMTG 498 
mobilisation is not yet known.  However, PLIN3 has also been observed in the mitochondria in 499 
skeletal muscle (Ramos et al., 2014) and PLIN3 knockdown in primary myotubes strongly 500 
reduces FA oxidation (Covington et al., 2015). We therefore cannot exclude the possibility that 501 
the increase in PLIN3 was related to mitochondrial adaptations.  502 
Despite there not being an increase in PLIN2 protein content, there was an increase in PLIN2+ 503 
LD in type I fibres. This occurred without a change in free PLIN2, but with an increase in the 504 
fraction of PLIN2 colocalising to LD in type I fibres. Together, this data suggests that the pre-505 
existing pool of PLIN2 that is already localised to LD is redistributed to newly formed LD 506 
following the HFHC diet. Previous research reported an increase in PLIN2+ LD without 507 
increases in PLIN2 protein expression in trained individuals that underwent lipid infusion 508 
(Shepherd et al., 2017), indicating that when there is sufficient PLIN2 in muscle fibres it can be 509 
redistributed to an expanding LD pool.  PLIN2 is associated with LD biogenesis primarily in 510 
adipocytes (Wolins et al., 2005) and murine fibroblasts (Imamura et al., 2002), and PLIN2 is 511 
localised at clusters in the cytoplasmic leaflet of the endoplasmic reticulum where LD biogenesis 512 
occurs (Robenek et al., 2006). Muscle-specific overexpression of PLIN2 increases IMTG storage 513 
in rats fed a high-fat diet without accumulation of lipid metabolite DAG (Bosma et al., 2012). 514 
Therefore, newly-formed LD may be labelled with PLIN2 leading to an increase in PLIN2+ LD, 515 
and theoretically this may support the storage of FA as IMTG rather than DAG.  516 
There was an increase in the fraction of PLIN5 colocalising to LD in type I fibres which 517 
occurred without any change in PLIN5+ LD This is indicative of PLIN5 colocalising to LD that 518 
already have PLIN5 associated (PLIN5+LD), rather than transforming PLIN5- LD into PLIN5+ 519 
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LD. PLIN5 has been primarily associated with oxidative capacity (Koves et al., 2013) and IMTG 520 
oxidation. For example PLIN5 protein expression is upregulated following endurance training 521 
(Louche et al., 2013; Shepherd et al., 2013) and during a moderate-intensity bout of exercise 522 
PLIN5+ LD are preferentially used (Shepherd et al., 2013). Recent findings suggest that PLIN5 523 
protein expression and lipid area fraction covered by PLIN5+ LD correlated positively with 524 
VO2max and ex vivo fatty acid oxidation but not insulin sensitivity (Gemmink et al., 2018). 525 
Increased LD content due to increases in PLIN5+ LD are associated with blunted reductions in 526 
insulin sensitivity following acute FFA elevation from prolonged fasting (Gemmink et al., 2016). 527 
Given PLIN5’s proposed role in regulating IMTG lipolysis, in the current study the increased 528 
fraction of PLIN5 to LD may function to support the consistent turnover of PLIN5+ LD pool and 529 
thus help to minimise accumulation of lipid metabolites.  530 
The use of previously validated immunofluorescence microscopy techniques (Shepherd et al., 531 
2012, 2013; Shepherd et al., 2017) to examine fibre-type and region specific changes in IMTG 532 
content and PLIN protein expression, in addition to colocalisation between PLIN proteins to LD 533 
following the HFHC diet is a clear strength of this study.  We should acknowledge though that 534 
the colocalisation analysis was only able to investigate the association between a single PLIN 535 
protein with LD. We cannot exclude the possibility, therefore, that LD have multiple PLIN 536 
proteins colocalised to them. For example, it is possible that the increases observed in PLIN3- 537 
LD and PLIN5- LD could be due to increases in LD coated with PLIN2. PLIN- LDs may also be 538 
newly formed LD that did not have enough PLIN associated to them to be detected by the lower 539 
detection limit of the microscope. Whether PLIN proteins work together or in isolation in 540 
regulating LD dynamics remains an avenue for future research. Studies employing subcellular 541 
fractionation in heart muscle, liver and adipose tissue have demonstrated that a large proportion 542 
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of PLIN proteins exist in the soluble cytosolic fraction (Harris et al., 2012; Kuramoto et al., 543 
2012). Cross-sectional images of muscle fibres in the current study showed that some of the 544 
cytosolic PLIN proteins appear in clusters throughout the cytosol and a proportion appeared as a 545 
diffuse stain throughout the muscle fibre. Because our analysis applies thresholds based on a 546 
fluorescence intensity to quantify PLIN proteins on cross-sectional images, we may have 547 
underestimated the total amount of soluble cytosolic PLINs. Due to limitations in subcellular 548 
fractionation in skeletal muscle tissue there is no existing information on the proportion of the 549 
soluble cytosolic PLIN pool in skeletal muscle and we therefore cannot determine the 550 
discrepancy between the imaging quantification method and the total amount existing in the 551 
cytosolic muscle fibre. 552 
Contrary to previous research (Garcia-Roves et al., 2007; Hancock et al., 2008), mitochondrial 553 
content was not increased following the HFHC diet. Increased mitochondrial content is an 554 
adaptation to enhance fatty acid β-oxidation fat oxidation especially in the face of increased FA 555 
supply (Jain et al., 2014). The lack of change in mitochondrial content in the current study could 556 
indicate that there was sufficient mitochondria already in muscle fibres in our physically active 557 
cohort to accommodate any required increase in FA oxidation.  Transmission electron 558 
microscopy and confocal immunofluorescence microscopy have confirmed that LDs are in close 559 
proximity to mitochondria in skeletal muscle (Hoppeler et al., 1999; Shaw et al., 2008). 560 
Younger, more insulin- sensitive individuals also have a greater fraction of LD in contact with 561 
the mitochondria (Crane et al., 2010). A limitation of the current study is that we could not 562 
measure the spatial interaction between mitochondria and LD because of sample size limitations. 563 
It is important to note that this spatial interaction, may have contributed to the observed increase 564 
in FA oxidation in the absence of an increase in mitochondrial content. 565 
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The present research was conducted in lean healthy individual for an acute period of 7-days. 566 
Future research should aim to investigate the effects of a HFHC diet on lipid storage and skeletal 567 
muscle insulin resistance in older, sedentary and overweight/obese population who are more 568 
susceptible to develop type 2 diabetes. Furthermore, extending the dietary period to a more long-569 
term setting would advance our understanding of the chronic effect of a HFHC diet and the 570 
mechanisms leading to skeletal muscle insulin resistance under these conditions.  571 
In conclusion, the present study has generated novel evidence that 7 days on a HFHC diet 572 
induces fibre type-specific increases in IMTG content and PLIN3 protein expression. Whist there 573 
was an increase in PLIN3 colocalising to LD, there was no change in PLIN3+ LD indicative of 574 
PLIN3 being directed to previously formed PLIN3+ LD rather than forming new PLIN3+ LD. In 575 
contrast the HFHC diet increased the number of PLIN2+ LD showing a redistribution of PLIN2 576 
to LD. We propose that the increase in IMTG reduces accumulation of lipid metabolites (DAG 577 
and ceramides), thus helping to maintain the insulin signalling pathway in skeletal muscle fibres 578 
as observed in our recent study (Parry et al., 2019).  579 
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Figures Legends 860 
Figure 1. Image analysis method for assessing IMTG and protein expression in cross-861 
sectional muscle fibres. Images for content analysis were obtained at 1.1x zoom on a 63x 862 
1.4NA confocal microscope. Grey scale images of the cell border identified with laminin (A) and 863 
of LD stained with BODIPY 493/503 (D). Erosion mask of 5 μm applied from the cell border to 864 
produce a peripheral region mask (B). Peripheral erosion mask inverted to create a mask for the 865 
central region of the cell (C). Masks B and C were applied to greyscale image of LD to produce 866 
extracted images of LD in the peripheral region of the cell (E) and the central region of the cell 867 
(F). Freehand ROI (green line) was manually drawn around central region of the cell to exclude 868 
LD from neighbouring cells (F). A selected intensity threshold was then applied to extracted 869 
images to represent positive signal for LD or PLIN proteins and the data was extracted to reveal 870 
percentage of area stained (IMTG and PLINs) as well as LD density (number of LDs expressed 871 
relative to area) and LD size (mean area of individual LDs). White bar = 25μm. 872 
Figure 2. Colocalisation analysis between LD and PLIN5. Images for colocalisation analysis 873 
were obtained using a 63x 1.4NA confocal microscope at 4x digital zoom at the central and 874 
peripheral region of the cell indicated by the two white boxes (A). LD were stained with 875 
BODIPY 493/503 (green; B), PLIN5 was stained red (C) and subsequent merged images (D) 876 
were used to calculate colocalisation. The overlapping area of LD and PLIN5 was extracted (E) 877 
to calculate the number of PLIN5+ LD and PLIN5- LD relative to the area of interest. White box 878 
in images B-E represent the peripheral area that was analysed when images at the periphery were 879 
obtained. White bar = 25μm (A) and 5 μm (B-E). The same method was repeated for 880 




Figure 3. TAG, DAG and ceramide concentrations in extracts of muscle samples obtained 883 
pre and post 7 days HFHC diet. There were no significant changes in overall TAG (A), DAG 884 
(B) or ceramide levels (C).  7 Days HFHC diet did not induce changes in any individual DAG 885 
species (D) or ceramide species (E). 886 
Figure 4. 7-days HFHC diet induces increases in IMTG content in type I fibres due to 887 
increases in LD density and size. 7 days HFHC diet increases type I fibre IMTG content (A), 888 
LD density (B) and LD size (C). Representative images of IMTG content pre and post HFHC 889 
diet in different fibre types obtained from confocal microscope with a 63x oil immersion 890 
objective and 1.1 digital zoom (D). Corresponding images of myosin heavy chain (MHC I) 891 
(stained red for type I fibres) and myosin heavy chain (MHC IIa) (stained blue for type IIa 892 
fibres), any fibres without a positive red or blue stain were assumed to be type IIx fibres (E). 893 
White bars represent 25 µm.* Significant difference for type I fibres vs type IIa and IIx fibres (P 894 
< 0.001). ‡ Significant difference for HFHC diet (P < 0.01). † Significant difference for central 895 
vs  peripheral region (P < 0.01). # Significant interaction between fibre type and HFHC diet (P < 896 
0.001). 897 
Figure 5. PLIN protein expression after pre and post 7 days HFHC diet. 7 days HFHC diet 898 
does not alter PLIN2 (A) or PLIN5 (C) protein expression but increases PLIN3 protein 899 
expression in type I fibres only (B). Representative images of PLIN2, PLIN3 and PLIN5 protein 900 
expression pre and post HFHC diet in type I fibres obtained from confocal microscope with a 901 
63x oil immersion objective and 1.1 digital zoom (D). White bars represent 25 µm *Significant 902 
difference for type I fibres vs type IIa and IIx fibres (P < 0.05). # Significant difference for type I 903 
fibres vs IIx fibres (P < 0.05). † Significant difference for peripheral region vs central region (P 904 




Figure 6. HFHC diet increases PLIN2+ LD in type I fibres only. 7 days HFHC diet increased 907 
PLIN2+ LD in type I fibres (A), whilst there were no changes in PLIN3+ LD (C) or PLIN5+ LD 908 
(E). PLIN2- LD (B) and PLIN5- LD (F) were not altered with the HFHC diet, whereas PLIN3- 909 
LD significant increased (D).* Significant difference for type I fibres vs type IIa (P < 0.01). † 910 
Significant difference for peripheral region vs central region (P < 0.01). Significant difference 911 
for peripheral region vs central region (P < 0.001). ‡ Significant difference for the HFHC diet (P 912 
< 0.05). # Significant interaction effect between fibre type and the HFHC diet (P < 0.001).  913 
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